This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Geir Åge Løset, PhD
CEO at Nextera AS
Speaker

Profile

Co-founder, Chief Executive Officer and Chief Scientific Officer of Nextera AS. PhD at the University of Oslo, followed by postdoctoral training at CSIRO Molecular and Health Technologies in Melbourne, Australia. More than 30 years of academic and industrial experience with focus on antibody, T cell receptor and HLA characterization and engineering. Dr. Løset has lead the development of Nextera’s technology platform since 2010, and up to 2020, in parallel as serving as senior researcher at the Centre for Immune Regulation at the Oslo University Hospital, associate member of the K.G. Jebsen Coeliac Disease Research Centre and Associate Professor at the Department of Biosciences at the University of Oslo, Norway.

Agenda Sessions

  • Optimized pIX Phage Display Discovery of Potent and Rare Therapeutic TCR-Like Antibody Candidates

    10:50